Medicare Enrolled

Dr. Gary Aaronson, DO

Pulmonary Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3998 RED LION ROAD, Philadelphia, PA 19114
2156128500
In practice since 2006 (19 years)
NPI: 1770672040 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aaronson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aaronson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aaronson

Dr. Gary Aaronson is a pulmonary disease specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aaronson performed 1,507 Medicare services across 998 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aaronson received a total of $116,688 from 55 pharmaceutical and/or device companies across 1206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aaronson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 15% volume in PA $116,688 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,507
Medicare services
Top 15% in PA for pulmonary disease
998
Unique beneficiaries
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~79 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
700 $96 $275
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
429 $62 $130
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
107 $126 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
71 $51 $190
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
54 $94 $245
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
50 $142 $360
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
36 $98 $190
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
18 $37 $120
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
16 $33 $120
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
15 $19 $125
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
11 $32 $55
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$116,688
Total received (2018-2024)
Avg $16,670/year across 7 years
Top 4% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
1,206
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100,077 (85.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,075 (13.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$536 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$28,839
2023
$13,406
2022
$9,278
2021
$20,438
2020
$14,655
2019
$18,241
2018
$11,831

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$25,563
Regeneron Healthcare Solutions, Inc.
$482
HARMONY BIOSCIENCES LLC
$459
GlaxoSmithKline, LLC.
$434
JAZZ PHARMACEUTICALS INC.
$247
GENZYME CORPORATION
$239
Bayer Healthcare Pharmaceuticals Inc.
$200
Actelion Pharmaceuticals US, Inc.
$188
Mallinckrodt Hospital Products Inc.
$126
Electromed, Inc.
$114
Amgen Inc.
$92
Insmed, Inc.
$85
Inspire Medical Systems, Inc.
$70
Takeda Pharmaceuticals U.S.A., Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$57
ANI Pharmaceuticals, Inc.
$55
Philips North America LLC
$45
Optinose US, Inc.
$38
Vifor Pharma, Inc.
$37
Baxter Healthcare
$35
Tactile Systems Technology Inc
$32
INOGEN, INC.
$29
Axsome Therapeutics, Inc.
$27
Mylan Specialty L.P.
$25
Sumitomo Pharma America, Inc.
$23
United Therapeutics Corporation
$21
Phadia US Inc.
$21
Pulmonx Corporation
$17
La Jolla Pharmaceutical Company
$16
Top 3 companies account for 91.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$77,641
Insmed, Inc.
$21,855
GlaxoSmithKline, LLC.
$3,511
Regeneron Healthcare Solutions, Inc.
$1,454
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,236
GENZYME CORPORATION
$1,115
Actelion Pharmaceuticals US, Inc.
$1,115
Mylan Specialty L.P.
$1,006
HARMONY BIOSCIENCES LLC
$760
Genentech USA, Inc.
$674
United Therapeutics Corporation
$563
Takeda Pharmaceuticals U.S.A., Inc.
$548
JAZZ PHARMACEUTICALS INC.
$470
Mallinckrodt Hospital Products Inc.
$414
Bayer Healthcare Pharmaceuticals Inc.
$400
Grifols USA, LLC
$322
Electromed, Inc.
$291
Advanced Respiratory, Inc
$282
Philips Electronics North America Corporation
$254
Harmony Biosciences LLC
$226
Amgen Inc.
$218
Sunovion Pharmaceuticals Inc.
$206
Jazz Pharmaceuticals Inc.
$189
Bayer HealthCare Pharmaceuticals Inc.
$178
Mallinckrodt Enterprises LLC
$175
Shire North American Group Inc
$127
ANI Pharmaceuticals, Inc.
$126
Merck Sharp & Dohme Corporation
$118
Janssen Pharmaceuticals, Inc
$101
Inspire Medical Systems, Inc.
$95
Novartis Pharmaceuticals Corporation
$95
Teva Pharmaceuticals USA, Inc.
$92
Axsome Therapeutics, Inc.
$89
PFIZER INC.
$87
Baxter Healthcare
$83
Circassia Pharmaceuticals Inc
$60
Philips North America LLC
$45
ADVANCED RESPIRATORY, INC
$43
Optinose US, Inc.
$38
Vifor Pharma, Inc.
$37
Inogen, Inc.
$33
Nabriva Therapeutics, plc
$33
Tactile Systems Technology Inc
$32
INOGEN, INC.
$29
Resmed Corp
$28
Covis Pharma GmBH
$25
Cumberland Pharmaceuticals, Inc.
$23
Sumitomo Pharma America, Inc.
$23
Daiichi Sankyo Inc.
$22
Phadia US Inc.
$21
Bio Products Laboratory USA, Inc.
$18
Pulmonx Corporation
$17
La Jolla Pharmaceutical Company
$16
Mallinckrodt LLC
$15
Shionogi Inc
$13
Top 3 companies account for 88.3% of all-time payments
Associated products mentioned in payments ›
(2928) NIV other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · ARALAST · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CHARTIS CATHETER · CINQAIR · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Esbriet · FASENRA · Fetroja · Flexitouch Plus · GEMTESA · GLASSIA · Gammaplex · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · KEYTRUDA · LONHALA MAGNAIR · Lunoa 1 0 · NIOX VERO · NONE · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The MetaNeb System · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vibativ · WAKIX · Wakix · XACDURO · XARELTO · XOLAIR · XYREM · XYWAV · Xenleta · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in PA.

Looking for a pulmonary disease specialist in Philadelphia?
Compare pulmonary diseases in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
271
Per 100K population
17.1
County median income
$60,698
Nearest hospital
JEFFERSON HEALTH- NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Aaronson is a clinical cardiology specialist, with above-average Medicare volume (top 15% in PA), with speaking/promotional industry engagement in the top 4% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Aaronson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Aaronson performed 700 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aaronson receive payments from pharmaceutical companies?
Yes. Dr. Aaronson received a total of $116,688 from 55 companies across 1,206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aaronson's costs compare to other pulmonary diseases in Philadelphia?
Dr. Aaronson's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aaronson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →